EUVIMEDDécouvrir EUVIMED
Beobachtungsstudie

Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant

Sarika Agarwal, Ashish Maheshwari iD, Meenu Bajpai iD

Journal of Clinical Apheresis · 2023

DOI: 10.1002/jca.22058 ↗

At a glance

Beobachtungsstudie in Journal of Clinical Apheresis, 2023. Written by Sarika Agarwal and 2 co-authors. Institution: Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Major MEDLINE topics: Liver Transplantation, Kidney Transplantation. Cited 4 times so far (Crossref); 20 references.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Introduction

Liver transplant is a life‐saving treatment, but due to the limited availability of suitable liver donors, ABO‐incompatible liver transplants (ABOi‐LT) are conducted to increase the availability of liver donors. Perioperative desensitization for ABOi‐LT is an established strategy to circumvent the risk of graft rejection. A single prolonged session can be performed to achieve the desired titers to avoid using multiple immunoadsorption (IA) columns or off‐label reuse of single‐use columns. This study retrospectively assessed the effectiveness of a single prolonged plasmapheresis session using IA as a desensitization strategy in live donor liver transplant (LDLT). Materials and methods This retrospective observational study conducted at a center for liver diseases in North India on six ABOi‐LDLT patients who underwent single prolonged IA sessions in the perioperative period from January 2018 to June 2021.

Results

Median baseline titer in patients was 320 (64, 1024). The median plasma volume adsorbed was 7.5 volumes (4, 8) per procedure, with a mean procedure time of 600 min (310‐753). The reduction in titer ranged from 4 log to 7 log reduction per procedure. Two patients developed transient hypotension during the procedure, which was managed successfully. The median duration of pre‐transplant hospital stay was 1.5 days (1, 3).

Conclusion

Desensitization therapy helps overcome the ABO barrier and decreases the waiting period before a transplant when ABO identical donors are unavailable. A single prolonged IA session reduces the cost of additional IA columns and hospital stay, thus making it a cost‐effective approach to desensitization.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationKidney TransplantationHumansCost-Benefit AnalysisRetrospective StudiesLiving DonorsPlasmapheresisBlood Group IncompatibilityABO Blood-Group SystemGraft Rejection

Author keywords

ABO-incompatible liver transplantdesensitization therapyimmunoadsorptionlarge volumeliver failureplasmapheresis

Substances

ABO Blood-Group System

Authors and institutions

  • Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.

ORCID profiles: Ashish Maheshwari, Meenu Bajpai

Cite

APA

Agarwal, S., Maheshwari, A., & Bajpai, M. (2023). Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22058

Vancouver

Agarwal S, Maheshwari A, Bajpai M. Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22058

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Sarika and Maheshwari, Ashish and Bajpai, Meenu},
  title = {Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant},
  journal = {Journal of Clinical Apheresis},
  year = {2023},
  doi = {10.1002/jca.22058}
}
Start for free →